Barbara Piccagli

Title: Barbara Piccagli: Innovator in Seizure Treatment

Introduction

Barbara Piccagli is a notable inventor based in Lugano, Switzerland. She has made significant contributions to the field of medicine, particularly in the treatment of epilepsy. Her innovative work focuses on improving the quality of life for patients suffering from AED-resistant seizures.

Latest Patents

Barbara holds a patent for the "Intrathecal administration of levetiracetam." This patent outlines methods of treatment, pharmaceutically acceptable solutions, and implantable devices designed for the intrathecal treatment of seizures that are resistant to antiepileptic drugs. Her research aims to provide effective solutions for patients who have not responded to conventional therapies.

Career Highlights

Throughout her career, Barbara has demonstrated a commitment to advancing medical science. Her work has been recognized for its potential to change the landscape of epilepsy treatment. She is currently associated with Sintetica S.A., a company known for its focus on innovative pharmaceutical solutions.

Collaborations

Barbara collaborates with esteemed colleagues, including Augusto Mitidieri and Elisabetta Donati. These partnerships enhance her research and contribute to the development of groundbreaking treatments.

Conclusion

Barbara Piccagli's contributions to the field of medicine, particularly in the treatment of seizures, highlight her role as an influential inventor. Her innovative approaches and collaborations continue to pave the way for advancements in healthcare.